Specialist, at Rashid Hospital, United Arab Emirates.
Dr. Laila Ibraheem Salameh is a highly accomplished professional with a Ph.D. in Molecular Medicine and Translational Research from the University of Sharjah (2017-2022). Her research focuses on the molecular mechanisms linking asthma and lung cancer. She holds an MPH from UAE University and a Bachelor’s in Nursing from the University of Jordan. Dr. Salameh has held various roles in the Dubai Health Authority, specializing in research, respiratory care, and graduate studies. She has earned several prestigious awards, including Best Researcher by DHA (2016). Her contributions to research, education, and healthcare have been recognized internationally. 🌍
Profile
Scopus
Education:
Dr. Salameh has a rich academic background, culminating in a Ph.D. in Molecular Medicine and Translational Research from the University of Sharjah (2017-2022), where she investigated the association between asthma and lung cancer. She also holds a Master of Public Health (MPH) from UAE University (2011-2013), specializing in healthcare policy and epidemiology. Prior to that, she earned a High Diploma in asthma management from Edge Hill University in the UK (2009-2010), further enhancing her expertise in respiratory care. She began her academic journey with a B.Sc. in Nursing from the University of Jordan (1998-2002), solidifying her foundation in healthcare. 🎓
Experience:
Dr. Salameh currently serves as a Specialist in Research and Graduate Studies at Dubai Health, starting in 2024. She also reviews research theses for medical residents at the Dubai Academic Health Corporation (DAHC). As a part-time lecturer at the University of Sharjah (2023), she has shared her expertise with budding healthcare professionals. Dr. Salameh previously held the position of Respiratory and Research Charge Nurse at Rashid Hospital (2007-2024). Her extensive experience in research, clinical care, and teaching makes her a leading figure in respiratory health and molecular medicine. 🏥
Research Interest:
Dr. Salameh’s research interests lie at the intersection of respiratory health and molecular medicine. She is particularly focused on exploring the molecular links between asthma and lung cancer, working to uncover the genetic and cellular mechanisms driving these diseases. Her expertise extends to public health, where she studies chronic obstructive pulmonary disease (COPD) and severe asthma. She has developed innovative methodologies, such as RNA linear amplification, to analyze archival tissue samples. Her work aims to improve diagnostics and treatment strategies for respiratory illnesses, contributing significantly to the field of molecular translational research. 🔬
Awards:
Dr. Laila Salameh has received numerous accolades for her contributions to healthcare and research. She was honored with the Best Researcher Award from Dubai Health Authority (2016) for her outstanding work in respiratory health. In 2013, she was recognized by the European Respiratory Society for presenting the best abstract on COPD case findings. In addition to these honors, she received the Gold Category Award from DHA in 2017 for her exemplary patient care. Her consistent contributions to research and public health have earned her international recognition. 🏅
Publications:
- Almarshoodi K., et al. (2024) “International Validation of the DECAF Score in COPD,” Hospital Pharmacy. DOI đź“„
- Salameh, L., et al. (2024) “Differential Response to Biologic Therapies in Severe Asthma,” Medical Research Archives. DOI đź“„
- Al-Bluwi, N., et al. (2024) “COVID-19 Severity Among Hospitalized Patients,” Journal of Epidemiology and Global Health. DOI đź“„
- Scelo, G., et al. (2023) “T2-related Comorbidities and Biologic Effectiveness in Asthma,” American Thoracic Society. đź“„
- Salameh, L., et al. (2023) “Vitamin D Supplementation in Asthma,” Nutrients. đź“„
Conclusion
Dr. Laila Ibraheem Salameh is a strong candidate for the Best Researcher Award, with significant achievements in respiratory medicine, translational research, and public health. Her academic accomplishments, innovative contributions, and recognition in the field, particularly in respiratory health, make her a deserving nominee. By expanding her international collaborations and securing additional research funding, she could elevate her profile even further in the global research landscape.